Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine - 1 Aug 2021

Bansal Naveen, Raturi Manish, Bansal Yashik

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Management
Share to Immune Evasion
Share to Immunization, Passive
Share to Multicenter Studies as Topic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pandemics

Share to Patient Selection

Share to Tertiary Care Centers

Share to Treatment Failure

Source

Open in PubMed Open full text

Identifiers

PMID: 34102319
DOI: 10.1016/j.tracli.2021.05.009
PMCID: PMC8178955

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India.PMID 34102319Read ↗

Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)Semantic proximity Read ↗

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide EvidenceSemantic proximity Read ↗

COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacySemantic proximity Read ↗

Efficacy and safety of convalescent plasma therapy for severe COVID-19 patients：case series study and literature reviewSemantic proximity Read ↗

COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic reviewSemantic proximity Read ↗

Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community SettingSemantic proximity Read ↗

Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?Semantic proximity Read ↗

COVID-19 convalescent plasma to treat hospitalised COVID-19 patients with or without underlying immunodeficiency: a randomized trialSemantic proximity Read ↗

A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnosticsSemantic proximity Read ↗

COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized TrialsSemantic proximity Read ↗

SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantationSemantic proximity Read ↗

‘A Most Equitable Drug’: How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug DevelopmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.